UK markets closed

Ultimovacs ASA (ULTIO.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
94.300.00 (0.00%)
At close: 03:31PM CET
Full screen
Previous close94.30
Open95.40
Bid0.00 x N/A
Ask0.00 x N/A
Day's range94.30 - 94.30
52-week range94.30 - 94.30
Volume142
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Ultimovacs ASA: Mandatory notification of trade by primary insider

    Oslo, 29 November 2022, a closely related party of Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 1,500 shares in the company at an average price of NOK 96.7058 per share. Following this transaction, Carlos de Sousa and closely related parties hold 21,556 shares and 416,035 share options in Ultimovacs ASA. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegia

  • Globe Newswire

    Ultimovacs ASA: New share capital registered

    Oslo, 21 November 2022, Ultimovacs ASA (the "Company") refers to the announcement published on 16 November 2022 regarding the issuance of new shares in connection with the Company's employee incentive program. The share capital increase related to the share issue of 130,700 new shares has been registered in the Norwegian Register of Business Enterprises, and the Company's new share capital is NOK 3,439,646.10, divided into 34,396,461 shares, each with a par value of NOK 0.10. For further informa

  • Globe Newswire

    Ultimovacs ASA: Share capital increase related to exercise of options

    Oslo, 16 November 2022, the Board of Directors of Ultimovacs ASA (the "Company") has resolved to increase the Company's share capital, related to the exercise of options, by NOK 13,070 through the issuance of 130,700 new shares, each with a par value of NOK 0.10. The resolution is based on an authorisation to increase the share capital granted by the Company's general meeting on 21 April 2022. Following the option exercise, 2,138,885 options are outstanding. The new shares are issued to employee